Unnamed: 0,title,date,stock,sentiment
40232.0,Affimed Highlights Study Design Of Its AFM13 REDIRECT Trial At The ASCO 2020 Virtual Meeting,2020-05-29 08:07:00-04:00,AFMD,neutral
40233.0,61 Biggest Movers From Yesterday,2020-05-20 04:50:00-04:00,AFMD,neutral
40234.0,Affimed: Q4 Earnings Insights,2020-04-28 08:30:00-04:00,AFMD,neutral
40235.0,Affimed  FY19 EPS €(0.50),2020-04-28 06:38:00-04:00,AFMD,neutral
40236.0,"Affimed Announces First Patient Successfully Dosed In First-in-Human Phase 1/2A Study Of AFM24 For The Treatment Of Advanced EGFR-Expressing Solid Tumors Including Colon, Lung And Other Cancers",2020-04-16 07:39:00-04:00,AFMD,positive
40237.0,"The Daily Biotech Pulse: Novartis Scraps Deal To Sell Sandoz Assets, Nevro Pre-Announces Q1 Shortfall, Affimed Granted Orphan Drug Designation",2020-04-02 07:57:00-04:00,AFMD,positive
40238.0,Affimed Reports FDA Orphan Drug Designation For AFM13 For Treatment Of T-Cell Lymphoma,2020-04-01 16:01:00-04:00,AFMD,neutral
40239.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,AFMD,negative
40240.0,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",2020-03-12 07:37:00-04:00,AFMD,negative
40241.0,Stocks That Hit 52-Week Lows On Wednesday,2020-03-11 11:41:00-04:00,AFMD,negative
40242.0,"The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment",2020-03-11 08:03:00-04:00,AFMD,positive
40243.0,Stocks That Hit 52-Week Lows On Tuesday,2020-03-10 10:37:00-04:00,AFMD,negative
40244.0,"The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index",2020-03-10 09:19:00-04:00,AFMD,negative
40245.0,26 Biotechnology Stocks Moving In Wednesday's After-Market Session,2020-01-22 23:28:00-05:00,AFMD,neutral
40246.0,36 Healthcare Stocks Moving In Wednesday's After-Market Session,2020-01-22 23:23:00-05:00,AFMD,neutral
40247.0,"The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings Estimate",2019-11-22 08:18:00-05:00,AFMD,positive
40248.0,"The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon",2019-11-21 07:22:00-05:00,AFMD,positive
40249.0,"The Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy Readout",2019-11-19 07:56:00-05:00,AFMD,neutral
40250.0,Affimed Q3 EPS €(0.17) Up From €(0.19) YoY,2019-11-19 07:35:00-05:00,AFMD,neutral
40251.0,"Earnings Scheduled For November 19, 2019",2019-11-19 04:01:00-05:00,AFMD,neutral
40252.0,The Week Ahead In Biotech: Clinical Readouts In Focus As Earnings Wind Down,2019-11-17 08:42:00-05:00,AFMD,neutral
40253.0,"The Daily Biotech Pulse: Amarin Braces For Vascepa Adcom Verdict, Biotechs On A Fundraising Spree, Zosano Makes Progress With Migraine Drug Filing",2019-11-14 08:07:00-05:00,AFMD,positive
40254.0,Stocks That Hit 52-Week Lows On Wednesday,2019-11-13 10:50:00-05:00,AFMD,negative
40255.0,"The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher",2019-11-13 07:10:00-05:00,AFMD,neutral
40256.0,80 Biggest Movers From Friday,2019-11-11 04:51:00-05:00,AFMD,neutral
40257.0,65 Stocks Moving In Friday's Mid-Day Session,2019-11-08 13:15:00-05:00,AFMD,neutral
40258.0,"The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut",2019-11-08 08:14:00-05:00,AFMD,neutral
40259.0,10 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-11-08 07:48:00-05:00,AFMD,neutral
40260.0,30 Stocks Moving in Friday's Pre-Market Session,2019-11-08 07:21:00-05:00,AFMD,neutral
40261.0,Affimed Prices 12M Share Offering At $2.50/Share,2019-11-08 06:31:00-05:00,AFMD,positive
40262.0,"10 Stocks To Watch For November 8, 2019",2019-11-08 04:50:00-05:00,AFMD,neutral
40263.0,"Affimed Reports Offering Of Common Stock, No Size Disclosed",2019-11-07 16:50:00-05:00,AFMD,negative
40264.0,Affimed Reports FDA Clearance Of Investigational New Drug To Commence First-In-Human Phase 1/2a Study Of AFM24,2019-11-07 16:49:00-05:00,AFMD,neutral
40265.0,63 Biggest Movers From Yesterday,2019-10-16 04:04:00-04:00,AFMD,neutral
40266.0,50 Healthcare Stocks Moving In Thursday's After-Market Session,2019-08-08 21:56:00-04:00,AFMD,neutral
40267.0,"Affimed Q2 EPS $(0.19) Misses $(0.14) Estimate, Sales $4.489M Beat $3.97M Estimate",2019-08-07 07:50:00-04:00,AFMD,negative
40268.0,"The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout",2019-08-07 07:34:00-04:00,AFMD,neutral
40269.0,Earnings Outlook For Affimed,2019-08-06 14:16:00-04:00,AFMD,neutral
40270.0,60 Biggest Movers From Yesterday,2019-06-25 05:12:00-04:00,AFMD,neutral
40271.0,40 Stocks Moving In Monday's Mid-Day Session,2019-06-24 12:35:00-04:00,AFMD,neutral
40272.0,Affimed Announces Clinical Data Update on Lead Product Candidate AFM13 in CD30+ lymphoma at ICML 2019,2019-06-24 05:58:00-04:00,AFMD,neutral
40273.0,"The Daily Biotech Pulse: Positive Readouts From Adamas And Ironwood, Sesen Bio To Offer Shares, Stoke Therapeutics Debut",2019-06-19 07:51:00-04:00,AFMD,positive
40274.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs",2019-06-15 12:38:00-04:00,AFMD,neutral
40275.0,52 Biggest Movers From Yesterday,2019-06-11 04:43:00-04:00,AFMD,neutral
40276.0,55 Biggest Movers From Yesterday,2019-05-23 04:56:00-04:00,AFMD,neutral
40277.0,41 Stocks Moving In Wednesday's Mid-Day Session,2019-05-22 12:32:00-04:00,AFMD,neutral
40278.0,Affimed NV shares are trading lower after the company announced it would terminate AFM11 Cancer Program.,2019-05-22 09:35:00-04:00,AFMD,negative
40279.0,28 Stocks Moving In Wednesday's Pre-Market Session,2019-05-22 08:29:00-04:00,AFMD,neutral
40280.0,"The Daily Biotech Pulse: Tocagen Tumbles, OncoSec Offering, Novartis Asthma Combo Drug Study",2019-05-22 07:34:00-04:00,AFMD,neutral
40281.0,"Affimed Q1 EPS €0.03 vs €(0.15) In Same Qtr. Last Year, Sales €11.353M vs €532K",2019-05-22 07:32:00-04:00,AFMD,neutral
40282.0,"Earnings Scheduled For May 22, 2019",2019-05-22 04:05:00-04:00,AFMD,neutral
40283.0,Affimed Q1 Earnings Preview,2019-05-21 14:16:00-04:00,AFMD,neutral
40284.0,Affimed Reports Submitted To FDA Added Info To Co.'s Initial Response Doc Submitted In Early Mar. Related To Clinical Hold On AFM11,2019-04-17 16:25:00-04:00,AFMD,neutral
40285.0,"Benzinga's Top Upgrades, Downgrades For March 28, 2019",2019-03-28 09:18:00-04:00,AFMD,positive
40286.0,"SVB Leerink Initiates Coverage On Affimed with Outperform Rating, Announces $8 Price Target",2019-03-28 07:17:00-04:00,AFMD,neutral
40287.0,"The Daily Biotech Pulse: FDA Nod For Novartis, Jazz Positive Late-Stage Data For Sleep Disorder Drug, Genfit IPO",2019-03-27 07:52:00-04:00,AFMD,positive
40288.0,"Affimed FY18 EPS €(0.32) vs €(0.69) In FY17, Sales €23.735M",2019-03-27 07:31:00-04:00,AFMD,neutral
40289.0,"Earnings Scheduled For March 27, 2019",2019-03-27 04:07:00-04:00,AFMD,neutral
40290.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs",2019-03-23 12:20:00-04:00,AFMD,neutral
40291.0,36 Stocks Moving In Tuesday's Pre-Market Session,2019-03-19 08:10:00-04:00,AFMD,neutral
40292.0,"The Daily Biotech Pulse: FDA Nod For Roche And Amphastar, Milestone Payment Kicks In For Affimed",2019-03-19 07:40:00-04:00,AFMD,neutral
40293.0,46 Biggest Movers From Yesterday,2018-12-11 05:15:00-05:00,AFMD,neutral
40294.0,28 Stocks Moving In Monday's Pre-Market Session,2018-12-03 08:13:00-05:00,AFMD,neutral
40295.0,"The Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOs",2018-12-02 17:51:00-05:00,AFMD,neutral
40296.0,"The Week Ahead In Biotech: ASH 2018, PDUFA Dates, Clinical Trials And Earnings",2018-11-25 09:41:00-05:00,AFMD,neutral
40297.0,"Affimed Q3 EPS $(0.19) Misses $(0.17) Estimate, Sales $206K Miss $470K Estimate",2018-11-07 08:10:00-05:00,AFMD,negative
40298.0,"The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Momenta Strikes Patent License Deal With AbbVie",2018-11-07 07:50:00-05:00,AFMD,negative
40299.0,"The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-11-04 13:35:00-05:00,AFMD,neutral
40300.0,76 Biggest Movers From Yesterday,2018-11-02 06:12:00-04:00,AFMD,neutral
40301.0,56 Stocks Moving In Thursday's Mid-Day Session,2018-11-01 12:59:00-04:00,AFMD,neutral
40302.0,"The Daily Biotech Pulse: Regulus Soars On Positive Pre-Clinical Data, Biogen Earnings, Proteostasis And Eiger to Offer Shares",2018-10-23 08:35:00-04:00,AFMD,positive
40303.0,Affimed F-3 Shows Filing For $150M Mixed Shelf Offering,2018-10-22 16:40:00-04:00,AFMD,neutral
40304.0,46 Biggest Movers From Yesterday,2018-10-10 05:08:00-04:00,AFMD,neutral
40305.0,Mid-Afternoon Market Update: Crude Oil Up Over 1%; Affimed Shares Plunge,2018-10-09 14:33:00-04:00,AFMD,negative
40306.0,36 Stocks Moving In Tuesday's Mid-Day Session,2018-10-09 12:39:00-04:00,AFMD,neutral
40307.0,Mid-Day Market Update: Blackbaud Drops On Lowered FY18 Outlook; Agile Therapeutics Shares Surge,2018-10-09 12:06:00-04:00,AFMD,positive
40308.0,Mid-Morning Market Update: Markets Mostly Lower; Helen of Troy Beats Q2 Estimates,2018-10-09 10:15:00-04:00,AFMD,negative
40309.0,26 Stocks Moving In Tuesday's Pre-Market Session,2018-10-09 08:19:00-04:00,AFMD,neutral
40310.0,"The Daily Biotech Pulse: Affimed's Cancer Drug Placed On Clinical Hold, Celgene's Positive Scalp Psoriasis Trial",2018-10-09 08:03:00-04:00,AFMD,negative
40311.0,UPDATE: BMO On Affimed Says Buy Shares On Weakness 'as clinical hold is more likely management caution than program ending',2018-10-09 07:09:00-04:00,AFMD,negative
40312.0,"BMO On Affimed Following Clinical Hold For AFM11: 'We believe AFM11 clinical hold is likely temporary, as the three SAEs (including one death) in the ALL/NHL trials were identified as neurotoxicities'; Maintains Outperform Rating, Has $5 Price Target",2018-10-09 07:08:00-04:00,AFMD,neutral
40313.0,44 Biggest Movers From Yesterday,2018-10-09 05:27:00-04:00,AFMD,neutral
40314.0,"5 Stocks To Watch For October 9, 2018",2018-10-09 05:10:00-04:00,AFMD,neutral
40315.0,"Affimed shares are trading down 23.5% after the company placed a clinical hold on AMF11 following serious adverse events in three patients, including one death and two life-threatening events.",2018-10-08 16:57:00-04:00,AFMD,negative
40316.0,"Affimed Shares Resume Trade, Now Down 22%%",2018-10-08 16:45:00-04:00,AFMD,positive
40317.0,"UPDATE: Affimed AFM11 Clinical Hold Initiated After 3 Patients Experienced Serious Adverse Events, Including 1 Death And 2 Life-Threatening Events",2018-10-08 16:19:00-04:00,AFMD,negative
40318.0,Affimed Shares To Resume Trade At 4:45 p.m. EDT,2018-10-08 16:19:00-04:00,AFMD,positive
40319.0,UPDATE: Affimed Says Clinical Hold For AFM11 Does Not Affect Ongoing Development Of Co.'s NK Cell Engager Programs,2018-10-08 16:19:00-04:00,AFMD,positive
40320.0,"UPDATE: Affimed Says Intends To Provide Update On AFM11 Upon Completion Of Evaluation With Global Health Authorities, Safety Monitoring Committees, Clinical Investigators",2018-10-08 16:18:00-04:00,AFMD,positive
40321.0,Affimed Reports Clinical Hold For AFM11 Phase 1 Program,2018-10-08 16:17:00-04:00,AFMD,neutral
40322.0,Affimed Shares Halted News Pending,2018-10-08 16:10:00-04:00,AFMD,positive
40323.0,20 Stocks Moving In Monday's Pre-Market Session,2018-10-01 08:03:00-04:00,AFMD,neutral
40324.0,56 Biggest Movers From Yesterday,2018-09-21 04:48:00-04:00,AFMD,neutral
40325.0,30 Stocks Moving In Thursday's Pre-Market Session,2018-09-20 08:15:00-04:00,AFMD,neutral
40326.0,"Affimed Shares Up 11% Over Last 15-20 Mins.; Not Seeing News To Justify Move Higher; However, Shares Rebounded From $4.60 Support Level, Price Now Flirting With $5 Level",2018-09-10 11:10:00-04:00,AFMD,positive
40327.0,22 Stocks Moving In Monday's Pre-Market Session,2018-09-10 08:03:00-04:00,AFMD,neutral
40328.0,62 Biggest Movers From Yesterday,2018-08-31 05:19:00-04:00,AFMD,neutral
40329.0,45 Stocks Moving In Thursday's Mid-Day Session,2018-08-30 12:44:00-04:00,AFMD,neutral
40330.0,"Stocks Which Set New 52-Week High Yesterday, August 29th",2018-08-30 11:47:00-04:00,AFMD,neutral
40331.0,Affimed Option Alert: Sep 21 $5 Calls Sweep (2) near the Bid: 500 @ $1.101 vs 6687 OI; Ref=$5.9427,2018-08-30 09:36:00-04:00,AFMD,positive
40332.0,30 Stocks Moving In Thursday's Pre-Market Session,2018-08-30 08:02:00-04:00,AFMD,neutral
40333.0,"The Daily Biotech Pulse: Verastem Gets New CFO, Mesoblast Earnings, Vertex's Precision Medicine Collaboration",2018-08-30 08:02:00-04:00,AFMD,neutral
40334.0,45 Biggest Movers From Yesterday,2018-08-30 05:38:00-04:00,AFMD,neutral
40335.0,34 Stocks Moving In Wednesday's Mid-Day Session,2018-08-29 12:30:00-04:00,AFMD,neutral
40336.0,"Stocks Which Set New 52-Week High Yesterday, August 28th",2018-08-29 11:13:00-04:00,AFMD,neutral
40337.0,25 Stocks Moving In Wednesday's Pre-Market Session,2018-08-29 08:00:00-04:00,AFMD,neutral
40338.0,"The Daily Biotech Pulse: Assertio Settles With Purdue, Emergent Biosolutions In M&A Mix, Novartis Eye Care Unit Recalls Stent",2018-08-29 07:54:00-04:00,AFMD,positive
40339.0,40 Biggest Movers From Yesterday,2018-08-29 05:18:00-04:00,AFMD,neutral
40340.0,Mid-Afternoon Market Update: Affimed Jumps On Collaboration With Roche's Genentech; Mitek Systems Shares Drop,2018-08-28 14:32:00-04:00,AFMD,neutral
40341.0,30 Stocks Moving In Tuesday's Mid-Day Session,2018-08-28 12:20:00-04:00,AFMD,neutral
40342.0,Mid-Day Market Update: DSW Climbs On Upbeat Results; Akcea Therapeutics Shares Slide,2018-08-28 12:12:00-04:00,AFMD,positive
40343.0,Mid-Morning Market Update: Markets Open Higher; Tiffany Beats Q2 Estimates,2018-08-28 10:13:00-04:00,AFMD,neutral
40344.0,Affimed Shares Soar On $5B Collaboration With Roche's Genentech,2018-08-28 10:12:00-04:00,AFMD,positive
40345.0,10 Biggest Price Target Changes For Tuesday,2018-08-28 09:48:00-04:00,AFMD,neutral
40346.0,"Jefferies Upgrades Affimed to Buy, Raises Price Target to $4",2018-08-28 09:03:00-04:00,AFMD,neutral
40347.0,Benzinga Pro's 5 Stocks To Watch Today,2018-08-28 08:54:00-04:00,AFMD,neutral
40348.0,"The Daily Biotech Pulse: Regulatory Roadblock For Akcea-Ionis, Affimed's Alliance, FDA Nod For Tetraphase's Antibiotic",2018-08-28 08:13:00-04:00,AFMD,neutral
40349.0,30 Stocks Moving In Tuesday's Pre-Market Session,2018-08-28 08:02:00-04:00,AFMD,neutral
40350.0,"10 Stocks To Watch For August 28, 2018",2018-08-28 05:18:00-04:00,AFMD,neutral
40351.0,6 Stock's Moving In Monday's After-Hours Session,2018-08-27 17:19:00-04:00,AFMD,neutral
40352.0,Affimed shares are up 106.3% after hours following announcement of cancer collaboration with Genentech.,2018-08-27 16:46:00-04:00,AFMD,negative
40353.0,"Affimed Shares Resume Trade, Now Up 87.5% at $3",2018-08-27 16:40:00-04:00,AFMD,positive
40354.0,"Affimed Announces Collaboration With Genentech To Develop Novel NK Cell Engager-based Immunotherapeutics For Multiple Cancer Targets; Co. Will Receive $96M Upfront And Committed Funding, Is Eligible For $5B Including Milestone Payments, Royalties",2018-08-27 16:12:00-04:00,AFMD,negative
40355.0,"Affimed Shares Halted, News Pending",2018-08-27 16:06:00-04:00,AFMD,positive
40356.0,"Affimed Q2 EPS €(0.13) vs €(0.18) In Same Qtr. Last Year, Sales €150K vs €508K Year Over Year",2018-08-08 07:48:00-04:00,AFMD,neutral
40357.0,40 Biggest Movers From Friday,2018-06-18 04:17:00-04:00,AFMD,neutral
40358.0,Mid-Afternoon Market Update: Crude Oil Down Over 3%; Canada Goose Shares Gain Following Strong Q4 Results,2018-06-15 14:32:00-04:00,AFMD,positive
40359.0,30 Stocks Moving In Friday's Mid-Day Session,2018-06-15 12:23:00-04:00,AFMD,neutral
40360.0,Mid-Day Market Update: Dow Down Over 200 Points; Affimed Shares Plummet,2018-06-15 12:16:00-04:00,AFMD,positive
40361.0,Affimed Shares Slide On Updated Hodgkin Lymphoma Drug Combo Data,2018-06-15 10:56:00-04:00,AFMD,positive
40362.0,Mid-Morning Market Update: Markets Open Lower; Adobe Beats Q2 Expectations,2018-06-15 10:19:00-04:00,AFMD,negative
40363.0,"Benzinga's Daily Biotech Pulse: Hematology Conference In The Spotlight, Dr. Reddy To Launch Generic Opioid Addiction Drug",2018-06-15 09:13:00-04:00,AFMD,neutral
40364.0,Affimed Earlier Announced Updated Data of AFM13 In Combination with Keytruda (Pembrolizumab) In Patients With Relapsed/Refractory Hodgkin Lymphoma Presented At EHA,2018-06-15 08:11:00-04:00,AFMD,neutral
40365.0,40 Biggest Movers From Yesterday,2018-06-15 04:56:00-04:00,AFMD,neutral
40366.0,31 Stocks Moving In Thursday's Mid-Day Session,2018-06-14 12:26:00-04:00,AFMD,neutral
40367.0,"Benzinga's Daily Biotech Pulse: Aytu Rallies On Earnings, Evolus Awaits FDA Verdict, BofA Conference Underway",2018-05-15 08:44:00-04:00,AFMD,positive
40368.0,"Affimed Q1 EPS C$(0.19) Misses $(0.18) Estimate, Sales C$399K Miss $470K Estimate",2018-05-15 07:46:00-04:00,AFMD,negative
40369.0,Affimed Launches ROCK Platform for Tailored Immune Cell Engagers,2018-05-03 06:16:00-04:00,AFMD,positive
40370.0,34 Biggest Movers From Yesterday,2018-04-06 04:21:00-04:00,AFMD,neutral
40371.0,28 Stocks Moving In Thursday's Mid-Day Session,2018-04-05 12:58:00-04:00,AFMD,neutral
40372.0,"Affimed Reports Q4 €(0.14) vs €(0.19) In Same Qtr. Last Year, Sales €636K vs €1.371M YoY",2018-03-20 07:33:00-04:00,AFMD,neutral
40373.0,"Earnings Scheduled For March 20, 2018",2018-03-20 04:46:00-04:00,AFMD,neutral
40374.0,Affimed Names Dr. Leila Alland Chief Medical Officer,2018-03-19 06:01:00-04:00,AFMD,neutral
40375.0,40 Biggest Movers From Yesterday,2018-02-14 04:56:00-05:00,AFMD,neutral
40376.0,Mid-Afternoon Market Update: Chegg Surges After Strong Q4 Results; Dare Bioscience Shares Slide,2018-02-13 14:30:00-05:00,AFMD,positive
40377.0,Affimed Shares Down 15.3% to $2.08 After Earlier Pricing Common Stock Offering At $2/Share,2018-02-13 14:25:00-05:00,AFMD,positive
40378.0,34 Stocks Moving In Tuesday's Mid-Day Session,2018-02-13 12:48:00-05:00,AFMD,neutral
40379.0,Mid-Day Market Update: GNC Climbs Following Announcement of $300M Investment From Harbin Pharmaceuticals; Helios And Matheson Shares Drop,2018-02-13 12:24:00-05:00,AFMD,neutral
40380.0,22 Stocks Moving In Tuesday's Pre-Market Session,2018-02-13 08:00:00-05:00,AFMD,neutral
40381.0,Affimed Prices 11.5M Share Public Offering of Common Stock @2.00/Share,2018-02-13 03:39:00-05:00,AFMD,positive
40382.0,9 Stocks Moving In Monday's After-Hours Session,2018-02-12 18:09:00-05:00,AFMD,neutral
40383.0,"Affimed Reports Offering Of Common Stock, No Size Disclosed",2018-02-12 16:05:00-05:00,AFMD,negative
40384.0,UPDATE Affimed Reports 'Early Data Suggest New Opportunity for AFM13 in CD30-positive Lymphoma',2018-02-01 08:32:00-05:00,AFMD,positive
40385.0,"Affimed Reports New Data Fro AFM13 From 2 Separate Trials In Hodgkin, CD30-Positive Lymphomas: Showed AFM13 In Combo With Keytruda Doubled Complete Response Rate In Patients",2018-02-01 08:31:00-05:00,AFMD,neutral
40386.0,"Affimed Earlier Offered Data From Phase 1b Combo Study Of AFM13 With Pembrolizumab At ASH: Closed Dose-Escalation Shows Combo Well Tolerated, 3-Mo. ORR Compares Favorably To Historical ORR Of Pembrolizumab Alone",2017-12-11 09:02:00-05:00,AFMD,positive
40387.0,"REMINDER: ASH Meeting Begins Tomorrow Dec. 9, Presenters Include Bellicum Pharmaceuticals, Affimed, Cellectis (Pediatric Data for UCART19), and Acceleron Pharma",2017-12-08 15:03:00-05:00,AFMD,neutral
40388.0,25 Stocks Moving In Friday's Pre-Market Session,2017-11-24 08:05:00-05:00,AFMD,neutral
40389.0,40 Biggest Movers From Yesterday,2017-11-16 04:46:00-05:00,AFMD,neutral
40390.0,"Affimed Reports Q3 EPS $(0.31) vs $(0.20) Est., Sales $938K vs $1.08M Est.",2017-11-07 07:43:00-05:00,AFMD,neutral
40391.0,12 Biggest Mid-Day Losers For Thursday,2017-09-21 12:52:00-04:00,AFMD,negative
40392.0,Affimed Reports Q2 EPS E$(0.24) vs E$(0.18) In Prior Year Period Sales E$2.06M,2017-08-01 07:34:00-04:00,AFMD,neutral
40393.0,15 Biggest Mid-Day Gainers For Friday,2017-07-14 12:32:00-04:00,AFMD,neutral
40394.0,"Benzinga's Top Upgrades, Downgrades For July 14, 2017",2017-07-14 09:27:00-04:00,AFMD,positive
40395.0,"SunTrust Robinson Humphrey Initiates Coverage On Affimed N.V. - Common Stock with Buy Rating, Announces $7.00 Price Target",2017-07-14 06:17:00-04:00,AFMD,neutral
40396.0,22 Stocks Moving In Thursday's Pre-Market Session,2017-06-29 08:36:00-04:00,AFMD,neutral
40397.0,15 Biggest Mid-Day Gainers For Tuesday,2017-06-27 12:31:00-04:00,AFMD,neutral
40398.0,22 Stocks Moving In Tuesday's Pre-Market Session,2017-06-27 08:21:00-04:00,AFMD,neutral
40399.0,22 Stocks Moving In Wednesday's Pre-Market Session,2017-06-07 08:05:00-04:00,AFMD,neutral
40400.0,Affimed Presents Data on First-in-Class BCMA-Targeting Immune Cell Engager AFM26 to Treat Multiple Myeloma #ASCO17,2017-06-06 05:03:00-04:00,AFMD,positive
40401.0,15 Biggest Mid-Day Gainers For Thursday,2017-05-18 12:31:00-04:00,AFMD,neutral
40402.0,25 Stocks Moving In Thursday's Pre-Market Session,2017-05-18 08:09:00-04:00,AFMD,neutral
40403.0,"Affimed Reports Q1 EPS E$(0.25) vs E$(0.19) In Prior Year Period, Sales E$1.93M vs E$399K In Prior Year Period",2017-05-17 07:32:00-04:00,AFMD,neutral
40404.0,"Affimed Reports Q4 EPS €(0.16) vs €(0.19) in Same Qtr. Last Year, Sales €1.4M",2017-03-30 07:31:00-04:00,AFMD,neutral
40405.0,13G from Hawkes Bay Master Investors on Affimed Shows New 5.04% Stake,2017-03-10 13:01:00-05:00,AFMD,neutral
40406.0,Mid-Afternoon Market Update: Skyworks Surges After Strong Earnings Report; Affimed Shares Drop,2017-01-20 14:38:00-05:00,AFMD,positive
40407.0,15 Biggest Mid-Day Losers For Friday,2017-01-20 13:01:00-05:00,AFMD,negative
40408.0,Mid-Day Market Update: Crude Oil Up 2.8%; Bristol-Myers Squibb Shares Slide After Opdivo Decision,2017-01-20 12:04:00-05:00,AFMD,negative
40409.0,Mid-Morning Market Update: Markets Open Higher; General Electric Revenue Misses Views,2017-01-20 09:55:00-05:00,AFMD,negative
40410.0,Affimed Reports Proposed Public Offering of Common Stock,2017-01-19 16:02:00-05:00,AFMD,neutral
40411.0,Filing from Affimed Shows Registration for $50M Offering Through Cowen,2016-12-15 16:35:00-05:00,AFMD,neutral
40412.0,Affimed Presents New Preclinical Data on Bi- and Trispecific Immune Cell Engagers at ASH 2016,2016-12-06 05:06:00-05:00,AFMD,positive
40413.0,Affimed to Present Preclinical Data on Bi- and Trispecific Immune Cell Engagers at ASH,2016-11-08 05:03:00-05:00,AFMD,positive
40414.0,"Affimed Reports Q3 EPS E$(0.24) vs. Est. $(0.26), Rev. E$1.15M vs. Est. $2.65M",2016-11-02 07:41:00-04:00,AFMD,neutral
40415.0,Leerink Swann Downgrades Affimed to Market Perform,2016-08-12 07:32:00-04:00,AFMD,neutral
40416.0,"Affimed Reports Q2 EPS $(0.19) vs. Est. $(0.23), Rev. $2.2M vs. Est. $2.1M",2016-08-10 07:34:00-04:00,AFMD,neutral
40417.0,"Earnings Scheduled For August 10, 2016",2016-08-10 04:55:00-04:00,AFMD,neutral
40418.0,Leerink Swann Downgrades Affimed to Market Perform,2016-05-19 08:42:00-04:00,AFMD,neutral
40419.0,"Affirmed Q1 EPS EPS EUR ($0.25) vs EUR ($0.17) est, Revenue EUR $1.94M vs EUR $1.88M est",2016-05-18 07:31:00-04:00,AFMD,neutral
40420.0,"Earnings Scheduled For May 18, 2016",2016-05-18 04:14:00-04:00,AFMD,neutral
40421.0,Affimed Presents Data on AFM13-mediated Innate/Adaptive Immune Crosstalk at  AACR Annual Meeting 2016,2016-04-21 05:05:00-04:00,AFMD,positive
40422.0,Affimed Presents Data on EGFRwt and EGFRvIII-targeting NK- and T-Cell TandAbs at AACR Annual Meeting 2016,2016-04-21 05:04:00-04:00,AFMD,neutral
40423.0,"BMO Capital Initiates Coverage on Affimed at Outperform, Announces $7.00 PT",2016-04-12 06:01:00-04:00,AFMD,neutral
40424.0,"Affimed Reports Q4 EPS E$(0.71) vs. Est. $(0.18), Rev. E$7.56M vs. Est. $1.71M",2016-03-30 07:33:00-04:00,AFMD,neutral
40425.0,"Earnings Scheduled For March 30, 2016",2016-03-30 04:03:00-04:00,AFMD,neutral
40426.0,Affimed to Collaborate with Merck to Evaluate AFM13 in Combination with KEYTRUDA for Patients with Hodgkin Lymphoma,2016-01-25 05:02:00-05:00,AFMD,neutral
40427.0,Affimed Names Dr. Joerg Windisch COO,2016-01-21 10:00:00-05:00,AFMD,neutral
40428.0,Affimed Names Dr. Andrew Evens to Scientific Advisory Board,2016-01-14 05:02:00-05:00,AFMD,neutral
40429.0,Affimed Presents Additional Data on Combination of AFM13 with Checkpoint Inhibitors at ASH,2015-12-06 09:17:00-05:00,AFMD,negative
40430.0,Wells Fargo Initiates Coverage on Affimed at Outperform,2015-12-04 07:56:00-05:00,AFMD,positive
40431.0,"Affirmed Reports Q3 EPS E$(0.25) vs. Est. E$(0.25), Rev. E$1.155M vs. Est. E$2.07M",2015-11-10 07:31:00-05:00,AFMD,neutral
40432.0,Affimed Presents Data on Potency of NK- and T-cell EGFRvIII TandAbs at SITC,2015-11-06 05:02:00-05:00,AFMD,neutral
40433.0,Affimed +4% After-Hours on Report of  Announces Significant Investment by an Existing Shareholder Of $21.8M,2015-10-14 16:23:00-04:00,AFMD,positive
40434.0,Affimed Announces Significant Investment by an Existing Shareholder Of $21.8M,2015-10-14 16:01:00-04:00,AFMD,positive
40435.0,"F-3 from Affimed Therapeutics Shows Reigstration for $150M Mixed Securities Shelf Offering, 9.66M Share Common Stock Offering by Selling Holders",2015-10-01 17:39:00-04:00,AFMD,positive
40436.0,Affimed Reports Q2 EPS E$(0.19) vs. Prior Year Quarter E$0.90,2015-08-04 07:33:00-04:00,AFMD,neutral
40437.0,5 NASDAQ Healthcare Stocks With The Highest ROA,2015-07-02 09:23:00-04:00,AFMD,neutral
40438.0,Benzinga's Top Initiations,2015-06-01 10:17:00-04:00,AFMD,positive
40439.0,"Oppenheimer Initiates Outperform On Affimed, Sees $14/Share",2015-06-01 10:05:00-04:00,AFMD,neutral
40440.0,"Oppenheimer Initiates Coverage on Affimed at Outperform, Announces $14.00 PT",2015-06-01 08:33:00-04:00,AFMD,neutral
40441.0,"Affirmed Reports Reports Q1 EPS E$(0.06) vs. Est. $(0.18), Rev. E$2.538M vs. Est. E$3.37M",2015-05-21 07:33:00-04:00,AFMD,neutral
40442.0,"Earnings Scheduled For May 21, 2015",2015-05-21 04:23:00-04:00,AFMD,neutral
40443.0,7 Biotech Stocks Moving Off The UBS Healthcare Conference,2015-05-19 14:16:00-04:00,AFMD,neutral
40444.0,Affimed Holder Brookside Capital Reports Passive Stake Of 7.06%,2015-05-13 15:22:00-04:00,AFMD,positive
40445.0,Morning Market Losers,2015-05-07 10:02:00-04:00,AFMD,negative
40446.0,Benzinga's Top #PreMarket Losers,2015-05-07 08:24:00-04:00,AFMD,negative
40447.0,Affimed Prices 5M Share Offering @$7.15/Share,2015-05-07 04:31:00-04:00,AFMD,positive
40448.0,Affirmed N.V. Announces Offering Of $35M Stock,2015-05-04 16:09:00-04:00,AFMD,neutral
40449.0,Afimed Files for Common Stock Offering of Up to $40.3M,2015-04-27 06:08:00-04:00,AFMD,neutral
40450.0,Biotech Investors: May 29th Could Be A Big Day,2015-04-21 14:39:00-04:00,AFMD,neutral
40451.0,6-K from Affimed Shows Q4 Loss of €0.22/Share vs Loss of €0.29/Share Est.,2015-03-25 07:43:00-04:00,AFMD,negative
40452.0,Affimed Names Dr. Martin Treder as Chief Scientific Officer,2015-01-20 05:25:00-05:00,AFMD,neutral
40453.0,Affimed Receives $3M Research Grant from German Federal Ministry of Education and Research,2015-01-07 05:14:00-05:00,AFMD,positive
40454.0,US Stock Futures Point To Lower Open Monday,2014-12-08 07:01:00-05:00,AFMD,negative
40455.0,Affimed Announces Presentation of Final Data for AFM13 Phase 1 Trial at ASH,2014-12-08 05:33:00-05:00,AFMD,neutral
40456.0,Morning Market Movers,2014-11-18 09:43:00-05:00,AFMD,neutral
40457.0,"Events for the Week of Nov. 17-21, 2014",2014-11-17 13:13:00-05:00,AFMD,neutral
40458.0,"Affimed Therapeutics Shares Open for Trade at $6.95/Share, IPO Priced at $7",2014-09-12 10:53:00-04:00,AFMD,positive
40459.0,"Affimed Therapeutics Shares Set to Open for Quote at 10:35 a.m. EDT, Expected to Open for Trade at 10:50 a.m.",2014-09-12 10:43:00-04:00,AFMD,positive
